Hartung HP - Search Results

1

Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

Hemmer B, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Ann Neurol. 2007 Oct;62(4):314-26. doi: 10.1002/ana.21289. Ann Neurol. 2007. PMID: 17969020 Review.

2

New concepts in the immunopathogenesis of multiple sclerosis.

Hemmer B, Archelos JJ, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Nat Rev Neurosci. 2002 Apr;3(4):291-301. doi: 10.1038/nrn784. Nat Rev Neurosci. 2002. PMID: 11967559 Review. No abstract available.

3

Immune mechanisms in chronic inflammatory demyelinating neuropathy.

Kieseier BC, Dalakas MC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Neurology. 2002 Dec 24;59(12 Suppl 6):S7-12. doi: 10.1212/wnl.59.12_suppl_6.s7. Neurology. 2002. PMID: 12499465 Review.

4

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.

Hartung HP, Gonsette R, König N, Kwiecinski H, Guseo A, Morrissey SP, Krapf H, Zwingers T; Mitoxantrone in Multiple Sclerosis Study Group (MIMS). Hartung HP, et al. Lancet. 2002 Dec 21-28;360(9350):2018-25. doi: 10.1016/S0140-6736(02)12023-X. Lancet. 2002. PMID: 12504397 Clinical Trial.

5

Remyelinating strategies for the treatment of multiple sclerosis.

Stangel M, Hartung HP. Stangel M, et al. Among authors: hartung hp. Prog Neurobiol. 2002 Dec;68(5):361-76. doi: 10.1016/s0301-0082(02)00105-3. Prog Neurobiol. 2002. PMID: 12531235 Review.

6

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: hartung hp. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

7

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.

Neuhaus O, Archelos JJ, Hartung HP. Neuhaus O, et al. Among authors: hartung hp. Trends Pharmacol Sci. 2003 Mar;24(3):131-8. doi: 10.1016/S0165-6147(03)00028-2. Trends Pharmacol Sci. 2003. PMID: 12628358 Review.

8

New immunopathologic insights into multiple sclerosis.

Hemmer B, Kieseier B, Cepok S, Hartung HP. Hemmer B, et al. Among authors: hartung hp. Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. doi: 10.1007/s11910-003-0085-y. Curr Neurol Neurosci Rep. 2003. PMID: 12691630 Free PMC article. Review.

9

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.

Barkhof F, Rocca M, Francis G, Van Waesberghe JH, Uitdehaag BM, Hommes OR, Hartung HP, Durelli L, Edan G, Fernández O, Seeldrayers P, Sørensen P, Margrie S, Rovaris M, Comi G, Filippi M; Early Treatment of Multiple Sclerosis Study Group. Barkhof F, et al. Among authors: hartung hp. Ann Neurol. 2003 Jun;53(6):718-24. doi: 10.1002/ana.10551. Ann Neurol. 2003. PMID: 12783417 Clinical Trial.

10

Multiple paradigm shifts in multiple sclerosis.

Kieseier BC, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Curr Opin Neurol. 2003 Jun;16(3):247-52. doi: 10.1097/01.wco.0000073923.19076.75. Curr Opin Neurol. 2003. PMID: 12858058 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results